AI accelerates biopharma from discovery to production, cutting cycle times by up to 40%.
Built-in data integrity is a bare minimum requirement in today’s BioPharmaceutical manufacturing. Good Manufacturing Practices (GMP) regulations of the Food and Drug Administration (FDA) highlight the ...
The University of Manchester's Centre of Excellence in Biopharmaceuticals (COEBP) has developed a biopharmaceutical manufacturing platform that allows rapid isolation of high-producing CHO cell ...
NEWARK, Del. and ATLANTA, Nov. 12, 2025 /PRNewswire/ -- The National Institute for Innovation in Manufacturing Biopharmaceuticals (NIIMBL) and the Open Applications Group, Inc. (OAGi) are proud to ...
The MarketWatch News Department was not involved in the creation of this content. Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and ...
SAN JOSE, Calif.--(BUSINESS WIRE)--The biopharmaceutical contract manufacturing market will reach $6.3 billion this year, a 12% increase from prior year. As pharmaceutical and biotechnology companies ...
NEW DELHI — Delaware Governor Matt Meyer on March 2 pitched his state as a key US partner for India in advanced ...
A bipartisan group of senators and representatives introduced legislation to establish a National Biopharmaceutical Manufacturing Center of Excellence (COE), inspired by recommendations from the ...
Sanofi is preparing a new vaccine and biopharmaceutical manufacturing facility in Singapore, located at Tuas Biomedical Park, Bloomberg reported Nov. 27. The plant, dubbed Modulus, represents an ...
The regulatory framework around biopharmaceutical manufacturing is exacting and continuously evolving. Companies must meet diverse global requirements while staying agile enough to deliver on ...
Artificial intelligence (AI) and the Internet of Things (IoT) are about to revolutionize the biopharmaceutical industry. As these technologies are combined and continue to evolve, they can drastically ...
Established five years ago as a first-of-its-kind manufacturer dedicated to broadening access to medicines and protecting biopharma supply chains against disruption, National Resilience is struggling ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results